Naziv |
Akcije |
Aleksandrina Vodolšak
Sinteza i biološka evaluacija heterocikličkih karbamata kao inhibitora humanih kolinesteraza / Bosak, Anita (mentor); Matošević, Ana (neposredni voditelj).
Zagreb, Prirodoslovno-matematički fakultet, Zagreb, . 2023 |
|
Matošević, Ana
Dizajn, sinteza i biološka evaluacija biskarbamata kao potencijalnih selektivnih inhibitora butirilkolinesteraze / Bosak, Anita (mentor);
Zagreb, Prirodoslovno-matematički fakultet, Zagreb, . 2023 |
|
Matošević, Ana; Bosak, Anita
Design, synthesis and biological evaluation of carbamates as cholinesterases inhibitors in the treatment of Alzheimer`s disease // 9th Conference of Young Chemists of Serbia: Book of Abstracts. Beograd: Serbian Chemical Society and Serbian Young Chemists’ Club, 2023. str. 13-13 |
|
Bartolić, Marija; Šušak, Petra; Arežina, Marko; Laučan, Matea; Ramić, Alma; Hrenar, Tomica; Primožič, Ines; Bosak, Anita
Quinuclidinium Based O-Alkyl Oximes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer's Disease // 10th EFMC Young Medicinal Chemists' Symposium - Book of Abstracts. Louvain-la-Neuve, Wallonia, Belgium: European Federation for Medicinal chemistry and Chemical biology (EFMC), 2023. str. 111-111 |
|
Novaković, Irena; Matošević, Ana; Milovanović, Vukan; Bartolić, Marija; Opsenica, Dejan; Sladić, Dušan; Bosak, Anita
1,4-benzoquinones as potent agents for Alzheimer`s disease treatment // IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry: Book of Abstracts. Louvain-la-Neuve, Wallonia, Belgium: European Federation for Medicinal chemistry and Chemical biology (EFMC), 2023. str. 270-270 |
|
Bartolić, Marija; Bosak, Anita
Multiple Problems, One Solution: Multi-Target Directed Ligands as the Future Treatment for Alzheimer's Disease // 7th Mini Symposium of Section of Medicinal and Pharmaceutical Chemistry: Book of Abstracts. Zagreb: HKD - sekcija za medicinsku i farmaceutsku kemiju, 2023. str. 3-3 |
|
Matošević, Ana; Bosak, Anita; Zandona, Antonio; Maraković, Nikola
Carbamates as potential new drugs in the treatment of Alzheimer`s disease // IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry: Book of Abstracts. Louvain-la-Neuve, Wallonia, Belgium: European Federation for Medicinal chemistry and Chemical biology (EFMC), 2023. str. 253-253 |
|
Matošević, Ana ; Opsenica, Dejan ; Spasić, Marta ; Maraković, Nikola ; Zandona, Antonio ; Žunec, Suzana ; Bartolić, Marija ; Kovarik, Zrinka ; Bosak, Anita
Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease // Chemico-biological interactions, 382 (2023), 110620, 13. doi: 10.1016/j.cbi.2023.110620 |
|
Bosak, Anita; Matošević, Ana; Opsenica, Dejan M.; Maraković, Nikola; Zandona, Antonio; Žunec, Suzana; Bartolić, Marija; Šegan, Sandra
N-octylamino derivatives of 4-aminoquinoline as possible multifuctional agents for Alzheimer`s disease treatment // IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry: Book of Abstracts. Louvain-la-Neuve, Wallonia, Belgium: European Federation for Medicinal chemistry and Chemical biology (EFMC), 2023. str. 117-117 |
|
Bartolić, Marija; Šušak, Petra; Arežina, Marko; Laučan, Matea; Ramić, Alma; Hrenar, Tomica; Primožič, Ines; Bosak, Anita
Quinuclidinium Based O-Alkyl Oximes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer's Disease // IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry: Book of Abstracts. Louvain-la-Neuve, Wallonia, Belgium: European Federation for Medicinal chemistry and Chemical biology (EFMC), 2023. str. 106-106 |
|